{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1363388845698875136.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1016/j.ymgme.2008.12.012"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S1096719208004757?httpAccept=text/xml"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S1096719208004757?httpAccept=text/plain"}}],"dc:title":[{"@value":"Murine muscle cell models for Pompe disease and their use in studying therapeutic approaches"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1383388845698875137","@type":"Researcher","foaf:name":[{"@value":"Shoichi Takikita"}]},{"@id":"https://cir.nii.ac.jp/crid/1383388845698875138","@type":"Researcher","foaf:name":[{"@value":"Rachel Myerowitz"}]},{"@id":"https://cir.nii.ac.jp/crid/1383388845698875140","@type":"Researcher","foaf:name":[{"@value":"Kristien Zaal"}]},{"@id":"https://cir.nii.ac.jp/crid/1383388845698875136","@type":"Researcher","foaf:name":[{"@value":"Nina Raben"}]},{"@id":"https://cir.nii.ac.jp/crid/1383388845698875139","@type":"Researcher","foaf:name":[{"@value":"Paul H. Plotz"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"10967192"}],"prism:publicationName":[{"@value":"Molecular Genetics and Metabolism"}],"dc:publisher":[{"@value":"Elsevier BV"}],"prism:publicationDate":"2009-04","prism:volume":"96","prism:number":"4","prism:startingPage":"208","prism:endingPage":"217"},"reviewed":"false","dc:rights":["https://www.elsevier.com/tdm/userlicense/1.0/"],"url":[{"@id":"https://api.elsevier.com/content/article/PII:S1096719208004757?httpAccept=text/xml"},{"@id":"https://api.elsevier.com/content/article/PII:S1096719208004757?httpAccept=text/plain"}],"createdAt":"2009-01-23","modifiedAt":"2019-05-17","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360846641759779968","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"A Skeletal Muscle Model of Infantile-onset Pompe Disease with Patient-specific iPS Cells"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1016/j.ymgme.2008.12.012"},{"@type":"CROSSREF","@value":"10.1038/s41598-017-14063-y_references_DOI_OB8Rkbskc7dpdAPXugPiVG3xqyA"}]}